We are live on ! Find out more
LS

Livforsakringsbolaget Skandia Portfolio holdings

AUM $2.58B
1-Year Est. Return 30.64%
This Fund
S&P 500
This Quarter Est. Return
+10.18%
1 Year Est. Return
+30.64%
3 Year Est. Return
+115.62%
5 Year Est. Return
+153.42%
10 Year Est. Return
+554.99%
AUM
$871M
AUM Growth
+$61.6M
Cap. Flow
+$2.65M
Cap. Flow %
0.3%
Top 10 Hldgs %
29.4%
Holding
613
New
29
Increased
45
Reduced
43
Closed
33

Top Buys

Rank Stock Value
1
LOW icon
Lowe's Companies
LOW
+$4.46M
2
HUM icon
Humana
HUM
+$2.21M
3
OC icon
Owens Corning
OC
+$1.96M
4
ADM icon
Archer Daniels Midland
ADM
+$1.83M
5
PTC icon
PTC
PTC
+$1.75M

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$3.76M
2
ARW icon
Arrow Electronics
ARW
+$3.01M
3
TSN icon
Tyson Foods
TSN
+$2.89M
4
COF icon
Capital One
COF
+$2.72M
5
TGT icon
Target
TGT
+$2.44M

Sector Composition

Rank Sector Weight
1 Technology 30.33%
2 Healthcare 21.38%
3 Financials 13.19%
4 Consumer Discretionary 12.54%
5 Industrials 7.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AAPL icon
1
Apple
AAPL
$4.41T
$64.3M 7.38%
494,616
– –
MSFT icon
2
Microsoft
MSFT
$3.66T
$49.5M 5.69%
206,572
+800
+0.4% +$192K
GOOGL icon
3
Alphabet (Google) Class A
GOOGL
$4.2T
$31.3M 3.6%
355,180
– –
JNJ icon
4
Johnson & Johnson
JNJ
$629B
$19.6M 2.25%
111,164
– –
AMZN icon
5
Amazon
AMZN
$2.88T
$17.6M 2.02%
209,120
+500
+0.2% +$49.4K
UNH icon
6
UnitedHealth
UNH
$364B
$16.9M 1.94%
31,858
– –
MRK icon
7
Merck
MRK
$328B
$15.4M 1.77%
137,863
– –
PFE icon
8
Pfizer
PFE
$150B
$15M 1.73%
293,427
– –
JPM icon
9
JPMorgan Chase
JPM
$971B
$13.6M 1.56%
101,392
– –
BAC icon
10
Bank of America
BAC
$453B
$13M 1.49%
391,152
– –
ABBV icon
11
AbbVie
ABBV
$440B
$12.4M 1.42%
76,572
-96
-0.1% -$14.7K
ORCL icon
12
Oracle
ORCL
$442B
$10.6M 1.22%
129,857
– –
GS icon
13
Goldman Sachs
GS
$302B
$10.1M 1.16%
29,438
+39
+0.1% +$13.6K
GILD icon
14
Gilead Sciences
GILD
$168B
$9.8M 1.13%
114,237
– –
AMGN icon
15
Amgen
AMGN
$225B
$9.69M 1.11%
36,896
– –
V icon
16
Visa
V
$671B
$9.21M 1.06%
44,322
– –
PG icon
17
Procter & Gamble
PG
$335B
$9.17M 1.05%
60,494
– –
CSCO icon
18
Cisco
CSCO
$488B
$9.16M 1.05%
192,257
– –
META icon
19
Meta Platforms (Facebook)
META
$1.47T
$8.98M 1.03%
74,654
– –
BMY icon
20
Bristol-Myers Squibb
BMY
$130B
$8.7M 1%
120,906
– –
CMI icon
21
Cummins
CMI
$87.8B
$8.63M 0.99%
35,634
– –
ELV icon
22
Elevance Health
ELV
$86.6B
$8.4M 0.96%
16,378
– –
MA icon
23
Mastercard
MA
$490B
$8.33M 0.96%
23,945
– –
AVGO icon
24
Broadcom
AVGO
$1.98T
$8.25M 0.95%
147,620
-320
-0.2% -$16K
QCOM icon
25
Qualcomm
QCOM
$171B
$8.24M 0.95%
74,923
– –
1
2 3 4 5

Similar funds

GFA
Gallagher Fiduciary Advisors Rolling Meadows, Illinois $2.58B AUM 8.97% 1-Year Est. Return
AAS
Ameritas Advisory Services Lincoln, Nebraska $2.58B AUM 18.84% 1-Year Est. Return
DCM
Dorsal Capital Management Redwood City, California $2.57B AUM 3.13% 1-Year Est. Return
PCM
Palestra Capital Management New York $2.57B AUM 29.93% 1-Year Est. Return
HWA
Heritage Wealth Advisors Richmond, Virginia $2.56B AUM 19.48% 1-Year Est. Return
GAG
GM Advisory Group Melville, New York $2.6B AUM 18.86% 1-Year Est. Return
ECP
Electron Capital Partners New York $2.55B AUM 87.77% 1-Year Est. Return
RCMF
RK Capital Management (Florida) Weston, Florida $2.6B AUM 83.27% 1-Year Est. Return

Livforsakringsbolaget Skandia's Q4 2022 Portfolio in Review

As of Q4 2022, Livforsakringsbolaget Skandia held 613 positions worth $871M, up 7.6% from $810M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Livforsakringsbolaget Skandia's Q4 2022 filing shows 29 new, 45 increased, 43 reduced and 33 closed positions. Its largest new stake was FirstCash: 16,100 shares worth $1.4M. The largest sale was Eli Lilly, an estimated $3.76M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 31% a quarter earlier, followed by Healthcare and Financials.

  • Livforsakringsbolaget Skandia's largest Q4 2022 buy was FirstCash: 16,100 shares worth $1.4M.
  • Livforsakringsbolaget Skandia added most to Lowe's Companies in Q4 2022, an estimated $4.46M increase.
  • Livforsakringsbolaget Skandia's biggest Q4 2022 reduction was Eli Lilly, cutting an estimated $3.76M.
  • Livforsakringsbolaget Skandia fully exited Walker & Dunlop in Q4 2022, selling an estimated $2.24M.
  • Livforsakringsbolaget Skandia's ten largest holdings make up 29% of its $871M portfolio in Q4 2022.
  • Livforsakringsbolaget Skandia opened 29 new positions and closed 33 in Q4 2022.
  • Livforsakringsbolaget Skandia's portfolio value rose 7.6% quarter-over-quarter to $871M.

Based on Livforsakringsbolaget Skandia's 13F filing for Q4 2022, filed 13 Feb 2023.